Literature DB >> 22705545

On the roles of polyvalent binding in immune recognition: perspectives in the nanoscience of immunology and the immune response to nanomedicines.

Thomas Vorup-Jensen1.   

Abstract

Immunology often conveys the image of large molecules, either in the soluble state or in the membrane of leukocytes, forming multiple contacts with a target for actions of the immune system. Avidity names the ability of a polyvalent molecule to form multiple connections of the same kind with ligands tethered to the same surface. Polyvalent interactions are vastly stronger than their monovalent equivalent. In the present review, the functional consequences of polyvalent interactions are explored in a perspective of recent theoretical advances in understanding the thermodynamics of such binding. From insights on the structural biology of soluble pattern recognition molecules as well as adhesion molecules in the cell membranes or in their proteolytically shed form, this review documents the prominent role of polyvalent interactions in making the immune system a formidable barrier to microbial infection as well as constituting a significant challenge to the application of nanomedicines.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22705545     DOI: 10.1016/j.addr.2012.06.003

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  21 in total

1.  Altered levels of soluble CD18 may associate immune mechanisms with outcome in sepsis.

Authors:  T W Kragstrup; K Juul-Madsen; S H Christiansen; X Zhang; J Krog; T Vorup-Jensen; A G Kjaergaard
Journal:  Clin Exp Immunol       Date:  2017-08-07       Impact factor: 4.330

2.  A comparison of binding surfaces for SPR biosensing using an antibody-antigen system and affinity distribution analysis.

Authors:  Huaying Zhao; Inna I Gorshkova; Gregory L Fu; Peter Schuck
Journal:  Methods       Date:  2012-12-24       Impact factor: 3.608

3.  Working together: interactions between vaccine antigens and adjuvants.

Authors:  Christopher B Fox; Ryan M Kramer; Lucien Barnes V; Quinton M Dowling; Thomas S Vedvick
Journal:  Ther Adv Vaccines       Date:  2013-05

4.  TUNABLE COMPLEMENT ACTIVATION BY PARTICLES WITH VARIABLE SIZE AND Fc DENSITY.

Authors:  Patricia M Pacheco; Benjamin LE; David White; Todd Sulchek
Journal:  Nano Life       Date:  2013-06

Review 5.  Polymeric drugs: Advances in the development of pharmacologically active polymers.

Authors:  Jing Li; Fei Yu; Yi Chen; David Oupický
Journal:  J Control Release       Date:  2015-09-26       Impact factor: 9.776

Review 6.  Considerations for combined immune checkpoint modulation and radiation treatment.

Authors:  Steven C Almo; Chandan Guha
Journal:  Radiat Res       Date:  2014-07-08       Impact factor: 2.841

7.  Structural Basis for Simvastatin Competitive Antagonism of Complement Receptor 3.

Authors:  Maria Risager Jensen; Goran Bajic; Xianwei Zhang; Anne Kjær Laustsen; Heidi Koldsø; Katrine Kirkeby Skeby; Birgit Schiøtt; Gregers R Andersen; Thomas Vorup-Jensen
Journal:  J Biol Chem       Date:  2016-06-23       Impact factor: 5.157

8.  Structural insight on the recognition of surface-bound opsonins by the integrin I domain of complement receptor 3.

Authors:  Goran Bajic; Laure Yatime; Robert B Sim; Thomas Vorup-Jensen; Gregers R Andersen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-24       Impact factor: 11.205

9.  Characterization of DNA-protein complexes by nanoparticle tracking analysis and their association with systemic lupus erythematosus.

Authors:  Kristian Juul-Madsen; Anne Troldborg; Thomas R Wittenborn; Mads G Axelsen; Huaying Zhao; Lasse H Klausen; Stefanie Luecke; Søren R Paludan; Kristian Stengaard-Pedersen; Mingdong Dong; Holger J Møller; Steffen Thiel; Henrik Jensen; Peter Schuck; Duncan S Sutherland; Søren E Degn; Thomas Vorup-Jensen
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-27       Impact factor: 11.205

10.  Nanoscale spatial dependence of avidity in an IgG1 antibody.

Authors:  Agnieszka Jendroszek; Magnus Kjaergaard
Journal:  Sci Rep       Date:  2021-06-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.